Chronic exercise improves myocardial inotropic reserve capacity through α1-adrenergic and protein kinase C-dependent effects in senescent Rats

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 59, Issue 11, 2004, Pages 1089-1098

  Korzick, Donna H ^a   Hunter, James C ^a   McDowell, Mark K ^a   Delp, Michael D ^b   Tickerhoof, Marlena M ^a   Carson, LaToya D ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBODY; CHELERYTHRINE; CITRATE SYNTHASE; PHENYLEPHRINE; PROTEIN KINASE C; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; SERINE;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE; INOTROPISM; ISOLATED HEART; MALE; NONHUMAN; PLANTARIS MUSCLE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; TREADMILL; WESTERN BLOTTING;

ANIMALIA;

EID: 11144328191     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/59.11.1089     Document Type: Article

References (43)

1. Lakatta EG, Sollott SJ. Perspectives on mammalian cardiovascular aging: humans to molecules. Comp Biochem Physiol A Mol Integr Physiol. 2002;132:699-721.
2. 1-adrenergic-mediated contraction and translocation of PKC in senescent rat heart. Am J Physiol Heart Circ Physiol. 2001;281:H581-H589.
3. Moore RL, Palmer BM. Exercise training and cellular adaptations of normal and diseased hearts. Exerc Sport Sci Rev. 1999;27:285-315.
4. Korzick DH, Moore RL. Chronic exercise enhances cardiac alpha 1-adrenergic inotropic responsiveness in rats with mild hypertension. Am J Physiol. 1996;271(6 Pt 2):H2599-H2608.
5. Spina RJ, Turner MJ, Ehsani AA. Exercise training enhances cardiac function in response to afterload stress in older men. Am J Physiol. 1997;272:H995-H1000.
6. Taffet G, Michael L, Tate C. Exercise training improves lusitropy by isoproterenol in papillary muscles from aged rats. J Appl Physiol. 1996;81:1488-1494.
7. Scarpace PJ, Shu Y, Turner N. Influence of exercise training on myocardial beta-adrenergic signal transduction: differential regulation with age. J Appl Physiol. 1994;77:737-741.
8. Clerk A, Sugden PH. Regulation of phospholipases C and D in rat ventricular myocytes: stimulation by endothelin-1, brady-kinin and phenylephrine. J Mol Cell Cardlol. 1997;29:1593-1604.
9. 1- adrenoceptor: inotropic effect and physiologic and pathologic implications. Life Sci. 1997;60:1305-1318.
10. Majewski H, Kotsonis P, Murphy T, Barrington M. Noradrenaline release and the effect of endogenous activation of the phospholipase C/protein kinase C signaling pathway in rat atria. Br J Pharmacol. 1997;121:1196-1202.
11. Baines CP, Zhang J, Wang GW, et al. Mitochondrial PKC epsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKC epsilon-MAPK interactions and differential MAPK activation in PKC epsilon-induced cardioprotection. Circ Res. 2002;90:390-397.
12. Carson LD, Korzick DH. Dose-dependent effects of acute exercise on PKC levels in rat heart: is PKC the heart's prophylactic? Acta Physiol Scand. 2003;178:1-10.
13. Dorn GW II, Mochly-Rosen D. Intracellular transport mechanisms of signal transducers. Annu Rev Physiol. 2002;64:407-429.
14. Newton AC. Analyzing protein kinase C activation. Methods Enzymol. 2002;345:499-506.
15. Dorn GW II, Souroujon MC, Liron T, et al. Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci U S A. 1999;96:12798-12803.
16. Braz JC, Bueno OF, De Windt LJ, Molkentin JD. PKC alpha regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2). J Cell Biol. 2002;156:905-919.
17. 1A-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy. Circ Res. 2001;89:343-350.
18. Srere P. Citrate Synthase. Methods Enzymol. 1969;13:3-5.
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
20. Ohno S, Mizuno K, Adachi Y, et al. Activation of novel protein kinases C delta and C epsilon upon mitogenic stimulation of quiescent rat 3Y1 fibroblasts. J Biol Chem. 1994;269:17495-17501.
21. Zhou HZ, Karliner JS, Gray MO. Moderate alcohol consumption induces sustained cardiac protection by activating PKC-epsilon and Akt. Am J Physiol Heart Circ Physiol. 2002;283:H165-H174.
22. Saito N, Kikkawa U, Nishizuka Y. The family of protein kinase C and membrane lipid mediators. J Diabetes Complic. 2002;16:4-8.
23. Sonnenburg ED, Gao T, Newton AC. The phosphoinositide-dependent kinase, PDK-1, phosphorylates conventional protein kinase C isozymes by a mechanism that is independent of phosphoinositide 3-kinase. J Biol Chem. 2001;276:45289-45297.
24. Braz JC, Gregory KN, Pathak A, et al. PKC-ε regulates cardiac contractility and propensity toward heart failure. Nat Med. 2004;10:248-254.
25. Heidkamp MC, Bayer AL, Martin JL, Samarel AM. Differential activation of mitogen-activated protein kinase cascades and apoptosis by protein kinase C epsilon and delta in neonatal rat ventricular myocytes. Circ Res. 2001;89:882-890.
26. Muth JN, Bodi I, Lewis W, Varadi G, Schwartz A. A Ca(2+)-dependent transgenic model of cardiac hypertrophy: a role for protein kinase C alpha. Circulation. 2001;103:140-147.
27. 1B-adrenergic receptor mRNAs in the heart of cardiomyopathic hamsters. J Mol Cell Cardiol. 1997;29:111-119.
28. Inagaki K, Hahn H, Dom GW II, Mochly-Rosen D. Additive protection of the ischemic heart ex vivo by combined treatment with α-protein kinase c inhibitor and α-protein kinase c activator. Circulation. 2003;108:869-875.
29. Mochly-Rosen D, Wu G, et al. Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKC epsilon translocation. Circ Res. 2000;86:1173-1179.
30. Ping P, Zhang J, Qiu Y, et al. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ε and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res. 1997;81:404-414.
31. Vondriska TM, Klein JB, Ping P. Use of functional proteomics to investigate PKC epsilon-mediated cardioprotection: the signaling module hypothesis. Am J Physiol Heart Circ Physiol. 2001;280: H1434-H1441.
32. Milligan G, Svoboday P, Brown C. Why are there so many adrenoceptor subtypes? Biochem Pharmacol. 1994;48:1059-1071.
33. 1-AR receptors is mediated by α subunits of Gq family. J Biol Chem. 1992;267:25798-25802.
34. 1-adrenergic signaling in aged rat heart is mediated by PKCα, PKCε and selective PKC binding protein (RACK) deficiency. Circulation. 1999;100:I567.
35. 2+ in cardiac myocytes. Circ Res. 1992;71:870-882.
36. Simonis G, Honold J, Schwarz K, Braun MU, Strasser RH. Regulation of the isozymes of protein kinase C in the surviving rat myocardium after myocardial infarction: distinct modulation for PKC-alpha and for PKC-delta. Basic Res Cardiol. 2002;97:223-231.
37. Hahn H, Marreez Y, Odley A, et al. Protein kinase C alpha negatively regulates systolic and diastolic function in pathological hypertrophy. Circ Res. 2003;93:1111-1119.
38. Hahn HS, Yussman MG, Toyokawa T, et al. Ischemic protection and myofibrillar cardiomyopathy: dose-dependent effects of in vivo δPKC inhibition. Circ Res. 2002;91:741-748.
39. 1B-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J Clin Invest. 2003;111:1783-1791.
40. Clerk A, Sugden PH. Untangling the Web: specific signaling from PKC isoforms to MAPK cascades. Circ Res. 2001;89:847-849.
41. Michel MC, Li Y, Heusch G. Mitogen-activated protein kinases in the heart. Naunyn Schmiedebergs Arch Pharmacol. 2001;363:245-266.
42. Strasser RH, Simonis G, Schon SP, et al. Two distinct mechanisms mediate a differential regulation of protein kinase C isozymes in acute and prolonged myocardial ischemia. Circ Res. 1999;85:77-87.
43. Gregory KN, Hahn H, Haghighi K, et al. Increased particulate partitioning of PKCe reverses susceptibility of phospholamban knockout hearts to ischemic injury. J Mol Cell Cardiol. 2004;36:313-318.